✦ LIBER ✦

A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patients

✍ Scribed by Y.-H. Lee; C.-Y. Hsu; C.-Y. Hsia; Y.-H. Huang; C.-W. Su; H.-C. Lin; Y.-Y. Chiou; T.-I. Huo

Book ID: 114704681
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 355 KB
Volume: 36
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2012.05226.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus-Based Immunosuppression Therap

Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria

✍ J. Zhou; Z. Wang; Z.-Q. Wu; S.-J. Qiu; Y. Yu; X.-W. Huang; Z.-Y. Tang; J. Fan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Bridging locoregional therapy enhances l

Bridging locoregional therapy enhances long-term survivals in hepatocellular carcinoma patients listed for liver transplant within the milan criteria: a 15-year experience

✍ Xing, M.; Sakaria, S.; Dhanasekaran, R.; Kokabi, N.; Camacho, J.C.; Parekh, S.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Liver Transplantation for Hepatocellular

Liver Transplantation for Hepatocellular Carcinoma Within Milan Criteria in Patients With Model For End-Stage Liver Disease Score Below 15: The Impact of the Etiology of Cirrhosis on Long-Term Survival

✍ Tandoi, F.; Ponte, E.; Saffioti, M.C.; Patrono, D.; Mirabella, S.; Lupo, F.; Rom 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 411 KB

P1301 THE ITA.LI.CA CRITERIA TO SELECT P

P1301 THE ITA.LI.CA CRITERIA TO SELECT PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATION: A NOVEL APPROACH BASED ON TRANSPLANT BENEFIT ANALYSIS

✍ Vitale, A.; Trevisani, F.; Farinati, F.; Burra, P.; Angeli, P.; Giannini, E.G.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 109 KB

The model for end-stage liver disease-ba

The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy

✍ Teh-Ia Huo; Han-Chieh Lin; Yi-Hsiang Huang; Jaw-Ching Wu; Jen-Huei Chiang; Pui-C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

## Abstract ## BACKGROUND The Japan Integrated Scoring (JIS) system was revealed as a better model for outcome prediction compared with the Cancer of Liver Italian Program system for hepatocellular carcinoma (HCC), and the Model for End‐Stage Liver Disease (MELD) was better as a prognostic predict